Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity.

MLA

Dan Jin, et al. “Combining CDK4/6 Inhibitors Ribociclib and Palbociclib with Cytotoxic Agents Does Not Enhance Cytotoxicity.” PLoS ONE, vol. 14, no. 10, Jan. 2019, p. e0223555. EBSCOhost, https://doi.org/10.1371/journal.pone.0223555.

APA

Dan Jin, Nguyen Tran, Nagheme Thomas, & David D Tran. (2019). Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity. PLoS ONE, 14(10), e0223555. https://doi.org/10.1371/journal.pone.0223555

Chicago

Dan Jin, Nguyen Tran, Nagheme Thomas, and David D Tran. 2019. “Combining CDK4/6 Inhibitors Ribociclib and Palbociclib with Cytotoxic Agents Does Not Enhance Cytotoxicity.” PLoS ONE 14 (10): e0223555. doi:10.1371/journal.pone.0223555.